Jerusalem Pharmaceuticals Co. announced unaudited consolidated preliminary financial results for year ended December 31, 2013. For the period, the company's net profit after taxes reached $2,162,958, compared with a net profit after taxes of $195,590 in the audited data for 2012, a net increase of 1,005.9%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.81 USD | 0.00% | -0.52% | +0.26% |
1st Jan change | Capi. | |
---|---|---|
+0.26% | 68.58M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- JPH Stock
- News Jerusalem Pharmaceuticals Co. Ltd.
- Jerusalem Pharmaceuticals Co. Announces Unaudited Consolidated Preliminary Financial Results for Year Ended December 31, 2013